Comment on: “Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japan...

por Farkouh, Raymond A., Hall-Murray, Cassandra, Klok, Rogier M., Hilton, Betsy, Isturiz, Raul E.
Publicado 2015

1384. Conceptual Economic Model Methodology for Infant Pneumococcal Conjugate Vaccine Program and its Impact on Antimicrobial Resistance

por Farkouh, Raymond, Nevo, Arianna, Uyei, Jennifer, Althouse, Benjamin, Hall-Murray, Cassandra, Lewnard, Joseph, Wasserman, Matthew
Publicado 2020

Sequential Administration of PCV13 Followed by PPSV23 Results in a More Robust Immune Response in PPSV23-Naïve Adults Age 60–64 Years

por Chilson, Erica, Atkinson, Bruce, Hall-Murray, Cassandra, Snow, Vincenza, Schmoele-Thoma, Beate, Isturiz, Raúl E, Scott, Daniel A
Publicado 2017